vTv Therapeutics Inc. — Director's Dealing 2021

Oct 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2021-10-19

Reporting Person: Prasad Deepa (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-19	Employee stock option (right to buy)	$1.47	A	2498635	Acquired	2031-10-19	Class A common stock (2498635)	Direct

Footnotes

F1: Options were granted as part of an inducement award and will vest on October 19, 2024 subject to continued employment (or earlier, upon achievement of certain performance measures).